Dudnik, Elizabeth
Reinhorn, Daniel
Holtzman, Liran
Article History
Accepted: 18 May 2021
First Online: 23 August 2021
Declarations
:
: Elizabeth Dudnik has received research funding from AstraZeneca, and has received personal fees for lectures, consulting or advisory services from Roche, Boehringer Ingelheim, AstraZeneca, Pfizer, MSD, Bristol-Myers Squibb, Novartis, Takeda, and Sanofi.Daniel Reinhorn declares that he has no conflict of interest.Liran Holtzman declares that he has no conflict of interest.